Vulvovaginal candidiasis (“yeast infections”) affect 75% of women at some point in their life. Approximately 10% of them will experience recurrent yeast infections, which have considerable emotional and economic ramifications and require prolonged antifungal treatment. Despite the prevalence of recurrent yeast infections, we lack an understanding of the human immune system and microbial population factors […]
Read More